Antineoplastic agent, Phosphatidylinositol 3-kinase (PI3K) inhibitor Medicines in UAE
183 medicines available
About Antineoplastic agent, Phosphatidylinositol 3-kinase (PI3K) inhibitor Medicines
This page lists all Antineoplastic agent, Phosphatidylinositol 3-kinase (PI3K) inhibitor medicines available in UAE pharmacies.
Click on any medicine name to view detailed information including uses, dosage, side effects, and availability.
Complete List of Antineoplastic agent, Phosphatidylinositol 3-kinase (PI3K) inhibitor Medicines
Class: | BRAF kinase inhibitor
Use: | Encorafenib (BRAFTOVI) is indicated for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by a...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer
Adult dose: | 150 mg orally once daily, taken at least 1 hour before or 2 hours afte...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer
Adult dose: | 150 mg orally once daily, taken at least 1 hour before or 2 hours afte...
Class: | Spleen tyrosine kinase (SYK) inhibitor
Use: | Treatment of chronic immune thrombocytopenic purpura (ITP) in adults who have had an insufficient response to other treatments
Adult dose: | ...
Class: | Spleen tyrosine kinase (SYK) inhibitor
Use: | Treatment of chronic immune thrombocytopenic purpura (ITP) in adults who have had an insufficient response to other treatments
Adult dose: | ...
Class: | Spleen tyrosine kinase (SYK) inhibitor
Use: | Treatment of chronic immune thrombocytopenia (ITP) in adults who have had an insufficient response to previous treatments
Adult dose: | 100 m...
Class: | Spleen tyrosine kinase (SYK) inhibitor
Use: | Treatment of chronic immune thrombocytopenic purpura (ITP) in adults who have had an insufficient response to other treatments
Adult dose: | ...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearra...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation
Adult dose: | 120 mg orally once daily, taken co...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation
Adult dose: | 120 mg orally once daily; may be r...
Class: | Antineoplastic agent, Phosphatidylinositol 3-kinase (PI3K) inhibitor
Use: | Treatment of chronic lymphocytic leukemia (CLL) with 17p deletion, follicular lymphoma (FL) after at least two pr...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of advanced or metastatic breast cancer, particularly in combination with capecitabine in patients with HER2-positive tumors
Adult dose: | 1250 ...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of advanced or metastatic breast cancer, particularly in combination with capecitabine in patients with HER2-positive tumors
Adult dose: | 1250 ...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of differentiated thyroid cancer, hepatocellular carcinoma, and renal cell carcinoma
Adult dose: | 10 mg orally once daily, taken with or withou...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) in patients who have progressed on or are intolerant to...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) in patients who have progressed on or are intolerant to...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adults with acute myeloid leukemia (AML) with a FLT3 mutation and for the treatment of aggressive systemic mastocytosis (ASM)
Adult dose: | 5...